Molecule in body that blocks antibody binding to SARS-CoV-2 discovered
Biliverdin attaches to a region of the SARS-CoV-2 Spike protein, stabilising it so that it is not able to expose its structure to antibodies, a new study has shown.
List view / Grid view
Biliverdin attaches to a region of the SARS-CoV-2 Spike protein, stabilising it so that it is not able to expose its structure to antibodies, a new study has shown.
22 April 2021 | By IDBS
Register today for our on-demand upcoming webinar and discover more on about Polar High-Throughput Process Development (HTPD).
Using newly developed assays, researchers have characterised the antibody response of individuals infected with SARS-CoV-2.
5,000+ drug target reagents for antibody, small molecule drug discovery and development, including immune checkpoints, cytokines and kinases.
Researchers have developed their previously created brain organoid to test for potential drugs against Creutzfeldt-Jakob disease (CJD).
Researchers have developed software that can design complex DNA nanodevices which could be used to deliver medicine while in the body.
An algorithm which continuously processes new data has been developed to allow researchers to access and analyse single-cell sequencing information.
A new COVID-19 vaccine could provide protection from severe infection from a range of coronaviruses, studies in pigs have shown.
Researchers have used CRISPR to create a new technology that can switch off almost any gene in cells, called CRISPRoff.
Scientists have created an assay to detect the protein cathepsin B in blood, a biomarker for a range of diseases.
Researchers have shown how different viruses such as HSV-1 and Zika can lead to microcephaly using brain organoids.
Researchers have developed an artificial intelligence to identify the best potential antibody drug from groups of up to a few thousand.
An international collaboration has led to the development of monkey embryos able to grow with injected human stem cells.
Dr Brittany Busse discusses why COVID-19 can influence the onset of diabetes and how this could shape the development of therapeutics.
Novel organoid models of cervical cancer and a healthy human cervix have been developed to study the condition and its progression.